Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Highlights
• The Company has conditionally agreed to acquire a company which is a university spin-out focused on patent protected technology for the early detection of lung cancer.
• A prospectus will be published in connection with the proposed Admission of the Company’s shares to the Standard Listing segment of the Official List and trading on the Main Market of the London Stock Exchange.
• The proposals will be subject to Bould shareholder approval at a General Meeting.
• The Company anticipates announcing full details of the Proposed Transaction and
publishing a prospectus on or before 27 April 2021.
• Should the proposals be approved by Bould shareholders at a to be convened General
Meeting the Company anticipates that its shares will be admitted to trading on the London Stock Exchange on or shortly after 14 May 2021.
Received this corporate update:
Bould Opportunities plc
("Bould Opportunities", “Bould” or the "Company")
Corporate Update
Notice of Annual General Meeting
Bould Opportunities is pleased to announce a corporate update, including further details regarding the Company’s proposed acquisition of a company focussed on early cancer detection (the “Proposed Transaction”), the intention for the Company’s shares to be admitted to the Standard Listing segment of the Official List and trading on the Main Market of the London Stock Exchange (“Admission”) and a notice of the Company’s Annual General Meeting.
The Company anticipates that it will be in a position to announce full details of the Proposed Transaction, publish the prospectus required for Admission and post a notice of the required General Meeting to approve the proposals within the next seven days. It is anticipated that the General Meeting will be held on the same day as the Annual General Meeting. Shareholders should note any General Meeting convened by the Company requires a shorter notice period to be given to shareholders than that required for the Company’s Annual General Meeting.
HarryCaul has been added to the other black bags.
He is trying to influence people to sell
they will probably be buying now, most important thing is the BOD have not sold.
Morning HH, I do not give any wrong information, that is my opinion and all the rns’s are there for everyone to decide.
-I am sure they are wealthier than me-:), but not sure if they are more clued up if they bought at much higher price than the current sp!
-Some of the more clued up also sold causing the sp to fall and some are well known P&D..ers (TERN comes to mind).
-I personally day traded rdgc but not a long term holding for me for the reasons above. My comment was manly related to Vela
and I would not go any further for the annoyance of the this bb readers.
ATB and have a good W/E
if he is planning to take part in the rto deal, then Vela will benefit more as it will be the admission price for the new company, which i expect will be less than the current sp for rdgc (they have been warned -:)
P.s Double blind study means the staff giving the medicine and the patients do not know which is tablet A or B, but the staff receiving data know (not blinded)
another similar drug has been approved recently:
https://finance.yahoo.com/news/vtv-therapeutics-vtvt-gets-breakthrough-130301989.html
P.s just added a bit to #spc as well
just an example:
https://www.chinadaily.com.cn/a/202008/18/WS5f3b980fa310834817261177.html
also there was something like that with #C4X recently
yes i think so, my buy at 14:28:06 shows as a sell
slowly, i am waiting for more funds to add here -:)